134 related articles for article (PubMed ID: 25081559)
1. Combined application of plasma mutagenesis and gene engineering leads to 5-oxomilbemycins A3/A4 as main components from Streptomyces bingchenggensis.
Wang HY; Zhang J; Zhang YJ; Zhang B; Liu CX; He HR; Wang XJ; Xiang WS
Appl Microbiol Biotechnol; 2014 Dec; 98(23):9703-12. PubMed ID: 25081559
[TBL] [Abstract][Full Text] [Related]
2. Genetic engineering of Streptomyces bingchenggensis to produce milbemycins A3/A4 as main components and eliminate the biosynthesis of nanchangmycin.
Zhang J; An J; Wang JJ; Yan YJ; He HR; Wang XJ; Xiang WS
Appl Microbiol Biotechnol; 2013 Dec; 97(23):10091-101. PubMed ID: 24077727
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a pathway-specific activator of milbemycin biosynthesis and improved milbemycin production by its overexpression in Streptomyces bingchenggensis.
Zhang Y; He H; Liu H; Wang H; Wang X; Xiang W
Microb Cell Fact; 2016 Sep; 15(1):152. PubMed ID: 27604457
[TBL] [Abstract][Full Text] [Related]
4. MilR2, a novel TetR family regulator involved in 5-oxomilbemycin A3/A4 biosynthesis in Streptomyces hygroscopicus.
Wei K; Wu Y; Li L; Jiang W; Hu J; Lu Y; Chen S
Appl Microbiol Biotechnol; 2018 Oct; 102(20):8841-8853. PubMed ID: 30121749
[TBL] [Abstract][Full Text] [Related]
5. Engineered biosynthesis of milbemycins in the avermectin high-producing strain Streptomyces avermitilis.
Kim MS; Cho WJ; Song MC; Park SW; Kim K; Kim E; Lee N; Nam SJ; Oh KH; Yoon YJ
Microb Cell Fact; 2017 Jan; 16(1):9. PubMed ID: 28095865
[TBL] [Abstract][Full Text] [Related]
6. Improved milbemycin production by engineering two Cytochromes P450 in Streptomyces bingchenggensis.
Wang H; Cheng X; Liu Y; Li S; Zhang Y; Wang X; Xiang W
Appl Microbiol Biotechnol; 2020 Apr; 104(7):2935-2946. PubMed ID: 32043186
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of 27-oxo, 27-hydroxymilbemycins A3 and A4 and novel 27-alkoxymilbemycins A3 and A4 from milbemycins A3 and A4 and their acaricidal activities.
Tsukiyama T; Tsukamoto Y; Suemoto H; Okamoto Y; Tamagawa Y; Kinoshita A; Ichinose R; Sato K
Biosci Biotechnol Biochem; 2002 Dec; 66(12):2606-13. PubMed ID: 12596855
[TBL] [Abstract][Full Text] [Related]
8. 5-ketoreductase from Streptomyces bingchengensis: overexpression and preliminary characterization.
Wang XJ; Wang CQ; Sun XL; Xiang WS
Biotechnol Lett; 2010 Oct; 32(10):1497-502. PubMed ID: 20563624
[TBL] [Abstract][Full Text] [Related]
9. Engineering of primary metabolic pathways for titer improvement of milbemycins in Streptomyces bingchenggensis.
Liu Y; Wang H; Li S; Zhang Y; Cheng X; Xiang W; Wang X
Appl Microbiol Biotechnol; 2021 Mar; 105(5):1875-1887. PubMed ID: 33564920
[TBL] [Abstract][Full Text] [Related]
10. [Construction of genetically engineered strain producing 5- oxomilbemycin by knocking out milF in Steptomyces hygroscopicus HS023].
Huang J; Lin J; Zhou M; Bai H
Wei Sheng Wu Xue Bao; 2015 Jan; 55(1):107-13. PubMed ID: 25958689
[TBL] [Abstract][Full Text] [Related]
11. Bioconversion of milbemycin-related compounds: biosynthetic pathway of milbemycins.
Nonaka K; Kumasaka C; Okamoto Y; Maruyama F; Yoshikawa H
J Antibiot (Tokyo); 1999 Feb; 52(2):109-16. PubMed ID: 10344564
[TBL] [Abstract][Full Text] [Related]
12. Microbial conversion of milbemycins: microbial conversion of milbemycins A4 and A3 by Streptomyces libani.
Nakagawa K; Sato K; Tsukamoto Y; Okazaki T; Torikata A
J Antibiot (Tokyo); 1994 Apr; 47(4):502-6. PubMed ID: 8195053
[No Abstract] [Full Text] [Related]
13. New seco-milbemycins from Streptomyces bingchenggensis: fermentation, isolation and structure elucidation.
Xiang WS; Wang JD; Fan HM; Wang XJ; Zhang J
J Antibiot (Tokyo); 2008 Jan; 61(1):27-32. PubMed ID: 18305356
[TBL] [Abstract][Full Text] [Related]
14. A novel spiro-heterocycle milbemycin metabolite from a genetically engineered strain of
Hao ZK; Zhang SY; Qi H; Xiang WS; Li JS; Wang JD
Nat Prod Res; 2023 Feb; 37(3):449-454. PubMed ID: 34542360
[TBL] [Abstract][Full Text] [Related]
15. Milbemycins alpha 11, alpha 12, alpha 13, alpha 14 and alpha 15: a new family of milbemycins from Streptomyces hygroscopicus subsp. aureolacrimosus. Taxonomy, fermentation, isolation, structure elucidation and biological properties.
Takahashi S; Miyaoka H; Tanaka K; Enokita R; Okazaki T
J Antibiot (Tokyo); 1993 Sep; 46(9):1364-71. PubMed ID: 8226315
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in the research of milbemycin biosynthesis and regulation as well as strategies for strain improvement.
Yan YS; Xia HY
Arch Microbiol; 2021 Dec; 203(10):5849-5857. PubMed ID: 34550409
[TBL] [Abstract][Full Text] [Related]
17. New milbemycin metabolites from the genetically engineered strain Streptomyces bingchenggensis BCJ60.
Li JS; Du MN; Zhang H; Zhang J; Zhang SY; Wang HY; Chen AL; Wang JD; Xiang WS
Nat Prod Res; 2017 Apr; 31(7):780-784. PubMed ID: 27748635
[TBL] [Abstract][Full Text] [Related]
18. An atypical two-component system, AtcR/AtcK, simultaneously regulates the biosynthesis of multiple secondary metabolites in
Yan Y-S; Zou L-S; Wei H-G; Yang M-Y; Yang Y-Q; Li X-F; Xia H-Y
Appl Environ Microbiol; 2024 Jan; 90(1):e0130023. PubMed ID: 38112424
[No Abstract] [Full Text] [Related]
19. Titer improvement of milbemycins via coordinating metabolic competition and transcriptional co-activation controlled by Streptomyces antibiotic regulatory protein family regulator in Streptomyces bingchenggensis.
Wang H; Liu Y; Cheng X; Zhang Y; Li S; Wang X; Xiang W
Biotechnol Bioeng; 2022 May; 119(5):1252-1263. PubMed ID: 35084043
[TBL] [Abstract][Full Text] [Related]
20. Bioconversion of milbemycin-related compounds: isolation and utilization of non-producer, strain RNBC-5-51.
Nonaka K; Tsukiyama T; Sato K; Kumasaka C; Maruyama F; Yoshikawa H
J Antibiot (Tokyo); 1999 Jul; 52(7):620-7. PubMed ID: 10513841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
